Evidence map›Paper›PMID 32240833›Full record

ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2021

Differences in Age at Onset of Symptoms, and Effects of Genetic Variants, in Patients With Early vs Late-Onset Idiopathic Chronic Pancreatitis in a North American Cohort.

Michele D Lewis, Jyothsna Talluri, C Mel Wilcox, Judah N Abberbock, Gong Tang, Darwin L Conwell, Peter A Banks, Gregory A Cote, Stuart Sherman, Samer Alkaade and 14 more

Open access · greenAbstract read
In one paragraph

Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Idiopathic chronic pancreatitis: clinical highlights.Therapeutic advances in gastroenterology · 2026
    Review
  3. Article
  4. Advances in acute and chronic pancreatitis.World journal of gastroenterology · 2023
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 14 institutions in 1 country.

Michele D LewisDivision of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida. Electronic address: Lewis.michele@mayo.edu.
Jyothsna TalluriDepartment of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
C Mel WilcoxDivision of Gastroenterology, University of Alabama at Birmingham, Birmingham, Alabama.
Judah N AbberbockDivision of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Gong TangDivision of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Darwin L ConwellDivision of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts.
Peter A BanksDivision of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts.
Gregory A CoteDivision of Gastroenterology, Indiana University School of Medicine, Indianapolis, Indiana.
Stuart ShermanDivision of Gastroenterology, Indiana University School of Medicine, Indianapolis, Indiana.
Samer AlkaadeDivision of Gastroenterology, Saint Louis University School of Medicine, St. Louis, Missouri.
Timothy B GardnerDivision of Gastroenterology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Michelle A AndersonDivision of Gastroenterology, University of Michigan School of Medicine, Ann Arbor, Michigan.
Bimaljit S SandhuDivision of Gastroenterology, Virginia Commonwealth University School of Medicine, Richmond, Virginia.
Thiruvengadam MunirajDivision of Gastroenterology, Griffin Hospital, Derby, Connecticut.
Chris E ForsmarkDivision of Gastroenterology, University of Florida College of Medicine, Gainesville, Florida.
Nalini GudaGI Associates, Milwaukee, Wisconsin.
Andres GelrudDivision of Gastroenterology, University of Chicago School of Medicine, Chicago, Illinois.
Joseph RomagnuoloDivision of Gastroenterology, Medical University of South Carolina, Charleston, South Carolina.
Randall BrandDivision of Gastroenterology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Jessica LaRuschDivision of Gastroenterology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Stephen T AmannDigestive Health Specialists, Tupelo, Mississippi.
Adam SlivkaDivision of Gastroenterology, University of Pittsburgh, Pittsburgh, Pennsylvania.
David C WhitcombDivision of Gastroenterology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Dhiraj YadavDivision of Gastroenterology, University of Pittsburgh, Pittsburgh, Pennsylvania.
University of Pittsburgh · USBrigham and Women's Hospital · USIndiana University School of MedicineDartmouth–Hitchcock Medical Center · USFlorida Digestive Health Specialists · USGriffin Hospital · USJacksonville College · USMedical University of South Carolina · USMichigan Medicine · USSaint Louis University · USUniversity of Alabama at Birmingham · USUniversity of Chicago · USUniversity of Florida · USVirginia Commonwealth University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
UNIVERSITY OF PITTSBURGH CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: BPCAUL1RR024153 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$73.9M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
UPMC Clinical Center for the Study of Chronic Pancreatitis and DiabetesU01DK108306 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Frederico G. S. Toledo, Dhiraj Yadav · 2015 to 2026
$6.4M
North American Pancreatitis Study 2 (NAPS2)R01DK061451 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WHITCOMB, DAVID CLEMENT · 2002 to 2010
$4.9M
U-01 CONSORTIUM FOR THE STUDY OF CHRONIC PANCREATITIS,DIABETES AND PANCREATIC CANCER CLINICAL CENTERSU01DK108320 · NIDDK · UNIVERSITY OF FLORIDA · PI CUSI, KENNETH, FORSMARK, CHRISTOPHER E · 2015 to 2024
$4.6M
NAPS2-AS: Race Dependent Risk for PancreatitisR01DK077906 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YADAV, DHIRAJ · 2010 to 2013
$2.3M
NAPS2 Continuation Genome Wide Association Study of PancreatitisR56DK061451 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WHITCOMB, DAVID CLEMENT · 2011 to 2011
$1.3M
NCATS NIH HHS UL1 TR000005NCATS NIH HHS UL1 TR001863NCRR NIH HHS UL1 RR024153NIDDK NIH HHS R01 DK061451NIDDK NIH HHS R01 DK077906NIDDK NIH HHS R56 DK061451NIDDK NIH HHS U01 DK108306NIDDK NIH HHS U01 DK108320
6 · The paper itself

Abstract

BACKGROUND &

aimsIdiopathic chronic pancreatitis (ICP) is the second most common subtype of CP. In 1994, researchers reported the bimodal age at onset of ICP symptoms: early onset ICP (EO-ICP; median age, 19.2 y) and late-onset ICP (LO-ICP; median age, 56.2 y). Ages of onset and clinical features of ICP differed from those of alcohol-related CP (ACP). However, variants in PRSS1 had not yet been associated with ICP. We reexamined ages of onset of ICP in a large, North American cohort of patients, and investigated the effects of genetic factors and alcohol use in patients with EO-ICP, LO-ICP, and ACP.

methodsWe performed a cross-sectional analysis of patients with CP of European ancestry enrolled in the North American Pancreatitis Study 2, a prospective study of 1195 patients with CP from 26 centers in the United States from August 2000 through December 2014. We compared age at onset of symptoms for 130 patients with CP who were lifetime abstainers from alcohol (61 patients with early onset and 69 patients with late onset), 308 light to moderate alcohol drinkers with CP, and 225 patients with ACP and heavy to very heavy alcohol use. DNA from available patients was analyzed for variants associated with CP in SPINK1, CFTR, and CTRC. The Kruskal-Wallis test was used to compare continuous variables across groups and based on genetic variants.

resultsMedian ages at onset of symptoms were 20 years for patients with EO-ICP and no alcohol use, 58 years for patients with LO-ICP and no alcohol use, 47 years for light to moderate alcohol drinkers with CP, and 44 years for patients with ACP. A higher proportion of patients with EO-ICP had constant pain (65%) than patients with LO-ICP (31%) (P = .04). A higher proportion of patients with ACP had pseudocysts (43%) than patients with EO-ICP (11%) (P = .001). A higher proportion of patients with EO-ICP had pathogenic variants in SPINK1, CFTR, or CTRC (49%) than patients with LO-ICP (23%), light to moderate alcohol drinking with CP (26%), or ACP (23%) (P = .001). Among patients with variants in SPINK1, those with EO-ICP had onset of symptoms at a median age of 12 years, and light to moderate alcohol drinkers with CP had an age at onset of 24 years. Among patients with variants in CFTR, light to moderate alcohol drinkers had an age at onset of symptoms of 41 years, but this variant did not affect age at onset of EO-ICP or ACP.

conclusionsWe confirmed previously reported ages at onset of symptoms for EO-ICP and LO-ICP in a North American cohort. We found differences in clinical features among patients with EO-ICP, LO-ICP, and ACP. Almost half of patients with EO-ICP have genetic variants associated with CP, compared with approximately one quarter of patients with LO-CP or ACP. Genetic variants affect ages at onset of symptoms in some groups.

Indexed as

Pancreatitis, ChronicAdultAge of OnsetChildCross-Sectional StudiesHumansMiddle AgedNorth AmericaProspective StudiesTrypsinTrypsin Inhibitor, Kazal PancreaticYoung AdultSPINK1 protein, humanTrypsinTrypsin Inhibitor, Kazal PancreaticDisease ProgressionMutationPrognosticRisk Factor

Identifiers

PMID32240833
PMCPMC7529676
OpenAlexW3014800253

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.